Iron metabolism and the innate immune response to infection

Microbes and Infection

Volumn 14, Issue 3, 2012, Pages 207-216

  Johnson, Erin E ^a   Wessling Resnick, Marianne ^b  

^a JOHN CARROLL UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepcidin; Inflammation; Innate immunity

Indexed keywords

CYTOKINE; FERRIC ION; FERRITIN; FERROPORTIN; FERROUS ION; HAPTOGLOBIN; HEME; HEMOGLOBIN; HEMOPEXIN; HEPCIDIN; IRON; LACTOFERRIN; LIPOCALIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; SIDEROCALIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BACTERIAL GROWTH; BACTERIAL INFECTION; BONE MARROW; DISEASE ASSOCIATION; ENDOCYTOSIS; ERYTHROCYTE; ERYTHROPOIESIS; HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION; INFECTION RISK; INNATE IMMUNITY; IRON ABSORPTION; IRON BINDING CAPACITY; IRON INTAKE; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; MALARIA; METABOLIC REGULATION; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SHORT SURVEY; TRYPANOSOMATID INFECTION; TUBERCULOSIS; VIRUS INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; IRON; LACTOFERRIN; MALARIA; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM; TUBERCULOSIS;

EID: 84856327464     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.10.001     Document Type: Short Survey

References (117)

1. Eisenbarth S.C., Flavell R.A. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol. Med. 2009, 1:92-98.
2. Khare S., Luc N., Dorfleutner A., Stehlik C. Inflammasomes and their activation. Crit. Rev. Immunol. 2010, 30:463-487.
3. Theil E.C. Iron homeostasis and nutritional iron deficiency. J. Nutr. 2011, 141:724S-728S.
4. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem. J. 2011, 434:365-381.
5. Ganz T. Hepcidin and iron regulation, 10 years Later. Blood 2011, 117:4425-4433.
6. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 2004, 113:1271-1276.
7. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
8. De Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., Daynes R.A., Kushner J.P., Li D., Ward D.M., Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 2010, 120:2395-2405.
9. Pietrangelo A. Hereditary hemochromatosis. Biochim. Biophys. Acta 2006, 1763:700-710.
10. Khan F.A., Fisher M.A., Khakoo R.A. Association of hemochromatosis with infectious diseases: expanding spectrum. Int. J. Infect. Dis. 2007, 11:482-487.
11. Olakanmi O., Schlesinger L.S., Britigan B.E. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J. Leukoc. Biol. 2007, 81:195-204.
12. Chlosta S., Fishman D.S., Harrington L., Johnson E.E., Knutson M.D., Wessling-Resnick M., Cherayil B.J. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 2006, 74:3065-3067.
13. Paradkar P.N., De Domenico I., Durchfort N., Zohn I., Kaplan J., Ward D.M. Iron depletion limits intracellular bacterial growth in macrophages. Blood 2008, 112:866-874.
14. Ward P.P., Uribe-Luna S., Conneely O.M. Lactoferrin and host defense. Biochem. Cell Biol. 2002, 80:95-102.
15. Afeltra A., Caccavo D., Ferri G.M., Addessi M.A., De Rosa F.G., Amoroso A., Bonomo L. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin. Exp. Immunol. 1997, 109:279-285.
16. Schaible U.E., Collins H.L., Priem F., Kaufmann S.H. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 2002, 196:1507-1513.
17. Britigan B.E., Hayek M.B., Doebbeling B.N., Fick R.B. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 1993, 61:5049-5055.
18. Singh P.K., Parsek M.R., Greenberg E.P., Welsh M.J. A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417:552-555.
19. Schaible U.E., Kaufmann S.H. Iron and microbial infection. Nat. Rev. Microbiol. 2004, 2:946-953.
20. Ward P.P., Mendoza-Meneses M., Park P.W., Conneely O.M. Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice. Am. J. Pathol. 2008, 172:1019-1029.
21. Borregaard N., Cowland J.B. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 2006, 19:211-215.
22. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 2002, 10:1033-1043.
23. Holmes M.A., Paulsene W., Jide X., Ratledge C., Strong R.K. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 2005, 13:29-41.
24. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
25. Martineau A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., Nawroly N., Packe G.E., Davidson R.N., Griffiths C.J., Wilkinson R.J. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest. 2007, 117:1988-1994.
26. Saiga H., Nishimura J., Kuwata H., Okuyama M., Matsumoto S., Sato S., Matsumoto M., Akira S., Yoshikai Y., Honda K., Yamamoto M., Takeda K. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J. Immunol. 2008, 181:8521-8527.
27. Landro L., Damas J.K., Flo T.H., Heggelund L., Ueland T., Tjonnfjord G.E., Espevik T., Aukrust P., Froland S.S. Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy. Clin. Exp. Immunol. 2008, 152:57-63.
28. Bao G., Clifton M., Hoette T.M., Mori K., Deng S.X., Qiu A., Viltard M., Williams D., Paragas N., Leete T., Kulkarni R., Li X., Lee B., Kalandadze A., Ratner A.J., Pizarro J.C., Schmidt-Ott K.M., Landry D.W., Raymond K.N., Strong R.K., Barasch J. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 2010, 6:602-609.
29. Devireddy L.R., Hart D.O., Goetz D.H., Green M.R. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 2010, 141:1006-1017.
30. Sengupta S., Tripathi J., Tandon R., Raje M., Roy R.P., Basu S.K., Mukhopadhyay A. Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket. J. Biol. Chem. 1999, 274:2758-2765.
31. Stijlemans B., Vankrunkelsven A., Brys L., Magez S., De Baetselier P. Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology 2008, 213:823-835.
32. Francis S.E., Sullivan D.J., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Ann. Rev. Microbiol. 1997, 51:97-123.
33. Paine A., Eiz-Vesper B., Blasczyk R., Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 2010, 80:1895-1903.
34. Epiphanio S., Mikolajczak S.A., Goncalves L.A., Pamplona A., Portugal S., Albuquerque S., Goldberg M., Rebelo S., Anderson D.G., Akinc A., Vornlocher H.P., Kappe S.H., Soares M.P., Mota M.M. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell. Host Microbe 2008, 3:331-338.
35. Silva-Herzog E., Detweiler C.S. Intracellular microbes and haemophagocytosis. Cell Microbiol. 2008, 10:2151-2158.
36. Byrd T.F., Horwitz M.A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 1989, 83:1457-1465.
37. Byrd T.F., Horwitz M.A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J. Clin. Invest. 1993, 91:969-976.
38. ter-Koltunoff M., Goren S., Nousbeck J., Feng C.G., Sher A., Ozato K., Azriel A., Levi B.Z. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J. Biol. Chem. 2008, 283:2724-2733.
39. Nairz M., Fritsche G., Brunner P., Talasz H., Hantke K., Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 2008, 38:1923-1936.
40. Clemens D.L., Horwitz M.A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 1996, 184:1349-1355.
41. Halaas O., Steigedal M., Haug M., Awuh J.A., Ryan L., Brech A., Sato S., Husebye H., Cangelosi G.A., Akira S., Strong R.K., Espevik T., Flo T.H. Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway. J. Infect. Dis. 2010, 201:783-792.
42. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993, 73:469-485.
43. Valdez Y., Grassl G.A., Guttman J.A., Coburn B., Gros P., Vallance B.A., Finlay B.B. Nramp1 drives an accelerated inflammatory response during Salmonella-induced colitis in mice. Cell Microbiol. 2009, 11:351-362.
44. Blackwell J.M., Goswami T., Evans C.A., Sibthorpe D., Papo N., White J.K., Searle S., Miller E.N., Peacock C.S., Mohammed H., Ibrahim M. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 2001, 3:773-784.
45. Cellier M.F., Courville P., Campion C. Nramp1 phagocyte intracellular metal withdrawal defense. Microb. Infect. 2007, 9:1662-1670.
46. Soe-Lin S., Apte S.S., Andriopoulos B., Andrews M.C., Schranzhofer M., Kahawita T., Garcia-Santos D., Ponka P. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis invivo. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5960-5965.
47. Forbes J.R., Gros P. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 2001, 9:397-403.
48. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., Weiss G. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 2007, 9:2126-2140.
49. Nairz M., Fritsche G., Crouch M.L., Barton H.C., Fang F.C., Weiss G. Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell Microbiol. 2009, 11:1365-1381.
50. Van Zandt K.E., Sow F.B., Florence W.C., Zwilling B.S., Satoskar A.R., Schlesinger L.S., Lafuse W.P. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J. Leukoc. Biol. 2008, 84:689-700.
51. Liu P.T., Modlin R.L. Human macrophage host defense against Mycobacterium tuberculosis. Curr. Opin. Immunol. 2008, 20:371-376.
52. Sturgill-Koszycki S., Schaible U.E., Russell D.G. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 1996, 15:6960-6968.
53. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., Allen R.D., Gluck S.L., Heuser J., Russell D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263:678-681.
54. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., Dolganov G., Efron B., Butcher P.D., Nathan C., Schoolnik G.K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal Environment. J. Exp. Med. 2003, 198:693-704.
55. Ratledge C., Dover L.G. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 2000, 54:881-941.
56. De Voss J.J., Rutter K., Schroeder B.G., Su H., Zhu Y., Barry C.E. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. U. S. A 2000, 97:1252-1257.
57. Cronje L., Edmondson N., Eisenach K.D., Bornman L. Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions. FEMS Immunol. Med. Microbiol. 2005, 45:103-112.
58. Lounis N., Truffot-Pernot C., Grosset J., Gordeuk V.R., Boelaert J.R. Iron and Mycobacterium tuberculosis infection. J. Clin. Virol. 2001, 20:123-126.
59. Lounis N., Maslo C., Truffot-Pernot C., Grosset J., Boelaert R.J. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis. Int. J. Tuberc. Lung Dis. 2003, 7:575-579.
60. Raghu B., Sarma G.R., Venkatesan P. Effect of iron on the growth and siderophore production of mycobacteria. Biochem. Mol. Biol. Int. 1993, 31:341-348.
61. Gomes-Pereira S., Rodrigues P.N., Appelberg R., Gomes M.S. Increased susceptibility to Mycobacterium avium in hemochromatosis protein HFE-deficient mice. Infect. Immun. 2008, 76:4713-4719.
62. Wang L., Johnson E.E., Shi H.N., Walker W.A., Wessling-Resnick M., Cherayil B.J. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 2008, 181:2723-2731.
63. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., Weiss G. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 2007, 9:2126-2140.
64. Nairz M., Fritsche G., Brunner P., Talasz H., Hantke K., Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 2008, 38:1923-1936.
65. Johnson E.E., Sandgren A., Cherayil B.J., Murray M., Wessling-Resnick M. Role of ferroportin in macrophage-mediated immunity. Infect. Immun. 2010, 78:5099-5106.
66. Murray M.J., Murray A.B., Murray M.B., Murray C.J. The adverse effect of iron repletion on the course of certain infections. Br. Med. J. 1978, 2:1113-1115.
67. Gangaidzo I.T., Moyo V.M., Mvundura E., Aggrey G., Murphree N.L., Khumalo H., Saungweme T., Kasvosve I., Gomo Z.A., Rouault T., Boelaert J.R., Gordeuk V.R. Association of pulmonary tuberculosis with increased dietary iron. J. Infect. Dis. 2001, 184:936-939.
68. Moyo V.M., Gangaidzo I.T., Gordeuk V.R., Kiire C.F., Macphail A.P. Tuberculosis and iron overload in Africa: a review. Cent. Afr. J. Med. 1997, 43:334-339.
69. Gordeuk V.R., McLaren C.E., Macphail A.P., Deichsel G., Bothwell T.H. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 1996, 87:3470-3476.
70. Gordeuk V., Mukiibi J., Hasstedt S.J., Samowitz W., Edwards C.Q., West G., Ndambire S., Emmanual J., Nkanza N., Chapanduka Z., Randall M., Boone P., Romano P., Martell R.W., Yamashita Y., Effler P., Brittenham G. Iron overload in Africa. Interaction between a gene and dietary iron content. N. Engl. J. Med. 1992, 326:95-100.
71. Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F. Acute HIV-1 infection. N. Engl. J. Med. 2011, 364:1943-1954.
72. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat. Med. 2002, 8:673-680.
73. Chen L., Xiong S., She H., Lin S.W., Wang J., Tsukamoto H. Iron causes interactions of TAK1, p21ras, and phosphatidylinositol 3-kinase in caveolae to activate IkappaB kinase in hepatic macrophages. J. Biol. Chem. 2007, 282:5582-5588.
74. Sappey C., Boelaert J.R., Legrand-Poels S., Forceille C., Favier A., Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res. Hum. Retroviruses 1995, 11:1049-1061.
75. Debebe Z., Ammosova T., Jerebtsova M., Kurantsin-Mills J., Niu X., Charles S., Richardson D.R., Ray P.E., Gordeuk V.R., Nekhai S. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology 2007, 367:324-333.
76. Xu M., Kashanchi F., Foster A., Rotimi J., Turner W., Gordeuk V.R., Nekhai S. Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 2010, 7:104.
77. Hoque M., Hanauske-Abel H.M., Palumbo P., Saxena D., D'Alliessi G.D., Park M.H., Pe'ery T., Mathews M.B. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A. Retrovirology 2009, 6:90.
78. Davies P.S., Enns C.A. Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells. J. Biol. Chem. 2004, 279:25085-25092.
79. Drakesmith H., Sweetland E., Schimanski L., Edwards J., Cowley D., Ashraf M., Bastin J., Townsend A.R. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15602-15607.
80. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebron J.A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P.J., Schatzman R.C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1472-1477.
81. Gross C.N., Irrinki A., Feder J.N., Enns C.A. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J. Biol. Chem. 1998, 273:22068-22074.
82. Drakesmith H., Chen N., Ledermann H., Screaton G., Townsend A., Xu X.N. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11017-11022.
83. Lundgren J.D., Mocroft A. Anemia and survival in human immunodeficiency virus. Clin. Infect. Dis. 2003, 37(Suppl 4):S297-S303.
84. Moore R.D. Human immunodeficiency virus infection, anemia, and survival. Clin. Infect. Dis. 1999, 29:44-49.
85. Friis H., Gomo E., Nyazema N., Ndhlovu P., Krarup H., Madsen P.H., Michaelsen K.F. Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J. Acquir. Immune Defic. Syndr. 2003, 33:74-81.
86. Gordeuk V.R., Onojobi G., Schneider M.F., Dawkins F.W., Delapenha R., Voloshin Y., von W., Bacon V.,M., Minkoff H., Levine A., Cohen M., Greenblatt R.M. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006, 91:739-743.
87. McDermid J.M., Jaye A., Schim van der Loeff M.F., Todd J., Bates C., Austin S., Jeffries D., Awasana A.A., Whittlex A.A., Prentice A. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J. Acquir. Immune. Defic. Syndr. 2007, 46:498-507.
88. McDermid J.M., van der Loeff M.F., Jaye A., Hennig B.J., Bates C., Todd J., Sirugo G., Hill A.V., Whittle H.C., Prentice A.M. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am. J. Clin. Nutr. 2009, 90:225-233.
89. Hafalla J.C., Silvie O., Matuschewski K. Cell biology and immunology of malaria. Immunol. Rev. 2011, 240:297-316.
90. Nweneka C.V., Doherty C.P., Cox S., Prentice A. Iron delocalisation in the pathogenesis of malarial anaemia. Trans. R. Soc. Trop. Med. Hyg. 2010, 104:175-184.
91. de Mast Q., van Dongen-Lases E.C., Swinkels D.W., Nieman A.E., Roestenberg M., Druilhe P., Arens T.A., Luty A.J., Hermsen C.C., Sauerwein R.W., van der Ven A.J. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br. J. Haematol. 2009, 145:657-664.
92. de Mast Q., Nadjm B., Reyburn H., Kemna E.H., Amos B., Laarakkers C.M., Silalye S., Verhoef H., Sauerwein R.W., Swinkels D.W., van der Ven A.J. Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J. Infect. Dis. 2009, 199:253-262.
93. Oppenheimer S.J., Gibson F.D., Macfarlane S.B., Moody J.B., Harrison C., Spencer A., Bunari O. Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:603-612.
94. Harvey P.W., Bell R.G., Nesheim M.C. Iron deficiency protects inbred mice against infection with Plasmodium chabaudi. Infect. Immun. 1985, 50:932-934.
95. Gordeuk V., Thuma P., Brittenham G., McLaren C., Parry D., Backenstose A., Biemba G., Msiska R., Holmes L., McKinley E., Vargas L., Gilkeson R., Poltera A.A. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 1992, 327:1473-1477.
96. Menendez C., Kahigwa E., Hirt R., Vounatsou P., Aponte J.J., Font F., Acosta C.J., Schellenberg D.M., Galindo C.M., Kimario J., Urassa H., Brabin B., Smith T.A., Kitua A.Y., Tanner M., Alonso P.L. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997, 350:844-850.
97. van Hensbroek M.B., Morris-Jones S., Meisner S., Jaffar S., Bayo L., Dackour R., Phillips C., Greenwood B.M. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:672-676.
98. Cardoso M.A., Ferreira M.U., Ribeiro G.S., Penteado M.D. H.F. ndrade Junior, Dietary iron supplementation does not aggravate experimental malaria in young rats. J. Nutr. 1996, 126:467-475.
99. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., Dhingra U., Kabole I., Deb S., Othman M.K., Kabole F.M. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367:133-143.
100. Nussbaum K., Honek J., Cadmus C.M., Efferth T. Trypanosomatid parasites causing neglected diseases. Curr. Med. Chem. 2010, 17:1594-1617.
101. Taylor M.C., Kelly J.M. Iron metabolism in trypanosomatids, and its crucial role in infection. Parasitology 2010, 137:899-917.
102. Gerrits H., Mussmann R., Bitter W., Kieft R., Borst P. The physiological significance of transferrin receptor variations in Trypanosoma brucei. Mol. Biochem. Parasitol. 2002, 119:237-247.
103. Breidbach T., Scory S., Krauth-Siegel R.L., Steverding D. Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine. Int. J. Parasitol. 2002, 32:473-479.
104. Merschjohann K., Steverding D. Invitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators. Kinetoplastid. Biol. Dis. 2006, 5:3.
105. Junqueira C., Caetano B., Bartholomeu D.C., Melo M.B., Ropert C., Rodrigues M.M., Gazzinelli R.T. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev. Mol. Med. 2010, 12:e29.
106. Lima M.F., Villalta F. Trypanosoma cruzi receptors for human transferrin and their role. Mol. Biochem. Parasitol. 1990, 38:245-252.
107. Lalonde R.G., Holbein B.E. Role of iron in Trypanosoma cruzi infection of mice. J. Clin. Invest. 1984, 73:470-476.
108. Pedrosa M.L., Silva M.E., Silva M.E., Silva M.E., Nicoli J.R., Vieira E.C. The effect of iron deficiency and iron overload on the evolution of Chagas disease produced by three strains of Trypanosoma cruzi in CFW mice. Comp. Biochem. Physiol. A: Physiol. 1990, 97:235-243.
109. Loo V.G., Lalonde R.G. Role of iron in intracellular growth of Trypanosoma cruzi. Infect. Immun. 1984, 45:726-730.
110. Arantes J.M., Pedrosa M.L., Martins H.R., Veloso V.M., de L.M., Bahia M.T., Tafuri W.L., Carneiro C.M. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice. Exp. Parasitol. 2007, 117:43-50.
111. Francisco A.F., de V A., Arantes J.M., Pedrosa M.L., Martins H.R., Silva M., Veloso V.M., de L.M., Bahia M.T., Tafuri W.L., Carneiro C.M. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice. Exp. Parasitol. 2008, 120:314-319.
112. Das N.K., Biswas S., Solanki S., Mukhopadhyay C.K. Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol. 2009, 11:83-94.
113. Huynh C., Sacks D.L., Andrews N.W. A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J. Exp. Med. 2006, 203:2363-2375.
114. Carvalho S., Cruz T., Santarem N., Castro H., Costa V., Tomas A.M. Heme as a source of iron to Leishmania infantum amastigotes. Acta Trop. 2009, 109:131-135.
115. Krishnamurthy G., Vikram R., Singh S.B., Patel N., Agarwal S., Mukhopadhyay G., Basu S.K., Mukhopadhyay A. Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket. J. Biol. Chem. 2005, 280:5884-5891.
116. Malafaia G., Marcon L.N., Pereira L.F., Pedrosa M.L., Rezende S.A. Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice. Exp. Parasitol. 2011, 127:719-723.
117. Bisti S., Konidou G., Boelaert J., Lebastard M., Soteriadou K. The prevention of the growth of Leishmania major progeny in BALB/c iron-loaded mice: a process coupled to increased oxidative burst, the amplitude and duration of which depend on initial parasite developmental stage and dose. Microbes Infect. 2006, 8:1464-1472.